Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

  • This share is currently suspended. It was suspended at a price of 0.742
  • There is currently no data for BGLF

Total Voting Rights

3 Oct 2022 15:44

RNS Number : 6062B
Blackstone Loan Financing Limited
03 October 2022
 

Blackstone Loan Financing Limited

 

3 October 2022

 

Total Voting Rights

 

Pursuant to Rule 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, Blackstone Loan Financing Limited ("the Company"), notifies the market of the following:

 

As at 5.00pm on 30 September 2022, the Company's issued share capital consisted of 452,498,032 Ordinary Shares of no par value, each carrying the right to 1 vote and denominated in Euros.

 

The total number of voting rights in the Company is, therefore, 452,498,032. The Company also holds 30,404,762 Ordinary Shares in treasury.

 

The above figure 452,498,032 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Please refer to the Company's Transaction in Own Shares announcement on 30 September 2022, with RNS number 4094B, for details of what the Company's total voting rights will be with effect from 4 October 2022.

 

For further information, please contact:

BNP Paribas S.A., Jersey Branch

IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP

Company Secretary

Tel: +44 (0) 1534 709178 / 813873

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPGWCUUPPGCW
Date   Source Headline
21st Dec 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
21st Nov 20231:17 pmRNSDIVIDEND CURRENCY ELECTION
21st Nov 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
13th Nov 20234:20 pmRNSQ3 2023 Report and Investor Call
20th Oct 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:00 amRNSDividend Declaration
26th Sep 20237:00 amRNSHalf-year Report
21st Sep 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
15th Sep 20231:21 pmRNSResult of Extraordinary General Meeting
25th Aug 20237:00 amRNSNotice of Extraordinary General Meeting
24th Aug 20234:07 pmRNSDirectorate Change
22nd Aug 20237:00 amRNSNet Asset Value and Publication of Monthly Report
9th Aug 20233:56 pmRNSQ2 2023 Report and Investor Call
26th Jul 20234:29 pmRNSBoard Update
26th Jul 20234:29 pmRNSResult of AGM
21st Jul 20237:00 amRNSNet Asset Value and Publication of Monthly Report
21st Jul 20237:00 amRNSDividend Declaration
10th Jul 20235:21 pmRNSNotice of Annual General Meeting
23rd Jun 20236:09 pmRNSProposed Managed Wind-Down of the Company
22nd Jun 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd May 20237:00 amRNSNet Asset Value and Publication of Monthly Report
11th May 20236:04 pmRNSQ1 2023 Report and Investor Call
28th Apr 20237:00 amRNSAnnual Financial Report
25th Apr 20237:00 amRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
3rd Apr 20234:54 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSNet Asset Value(s)
17th Mar 20237:00 amRNSResults of Shareholder Consultation
2nd Mar 20235:31 pmRNSTransaction in Own Shares
2nd Mar 20235:08 pmRNSTransaction in Own Shares
1st Mar 20235:11 pmRNSTransaction in Own Shares
1st Mar 20233:05 pmRNSTotal Voting Rights
24th Feb 20234:18 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20237:00 amRNSNet Asset Value and Publication of Monthly Report
10th Feb 20234:48 pmRNSTransaction in Own Shares
10th Feb 20234:12 pmRNSNon-material change to Investment Policy
10th Feb 20231:58 pmRNSQ4 2022 Report and Investor Call
1st Feb 20233:36 pmRNSHolding(s) in Company
1st Feb 20231:10 pmRNSTotal Voting Rights
26th Jan 20239:37 amRNSShareholder Consultation
23rd Jan 20233:13 pmRNSInvestor Call
23rd Jan 202311:38 amRNSShare Repurchase Programme
23rd Jan 20237:00 amRNSDividend Declaration
23rd Jan 20237:00 amRNSNet Asset Value(s)
19th Jan 20234:44 pmRNSTransaction in Own Shares
16th Jan 20235:13 pmRNSHolding(s) in Company
16th Jan 20234:53 pmRNSTransaction in Own Shares
13th Jan 20234:36 pmRNSTransaction in Own Shares
12th Jan 20234:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.